Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
1.070
-0.020 (-1.83%)
Nov 22, 2024, 4:00 PM EST - Market closed
Alterity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 22, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 10 | 14 | 11 | 22 | 44 | 12 | |
| Market Cap Growth | 23.14% | 23.14% | -47.27% | -50.72% | 259.32% | -30.44% | |
| Enterprise Value | 2 | 6 | -5 | -4 | 17 | 4 | |
| Last Close Price | 1.07 | 1.81 | 2.79 | 6.11 | 13.00 | 11.90 | |
| PS Ratio | 5.22 | 5.22 | 4.36 | 6.11 | 13.45 | - | |
| PB Ratio | 1.52 | 1.52 | 0.75 | 0.88 | 1.92 | 2.47 | |
| P/TBV Ratio | 1.52 | 1.52 | 0.75 | 0.88 | 1.92 | 2.47 | |
| EV/Sales Ratio | 0.84 | 2.22 | - | - | 5.37 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover | 0.17 | 0.17 | 0.11 | 0.14 | 0.20 | - | |
| Quick Ratio | 3.10 | 3.10 | 5.58 | 6.79 | 10.56 | 3.41 | |
| Current Ratio | 3.54 | 3.54 | 6.17 | 7.07 | 10.92 | 3.62 | |
| Return on Equity (ROE) | -104.47% | -104.47% | -47.38% | -38.97% | -81.39% | -113.53% | |
| Return on Assets (ROA) | -52.66% | -52.66% | -26.64% | -25.85% | -43.62% | -58.40% | |
| Return on Capital (ROIC) | -66.27% | -66.27% | -31.22% | -29.31% | -50.30% | -73.35% | |
| Earnings Yield | -123.27% | -91.15% | -80.84% | -41.06% | -26.24% | -76.31% | |
| FCF Yield | -79.25% | -60.11% | -117.35% | -39.71% | -29.72% | -53.57% | |
| Buyback Yield / Dilution | -50.29% | -50.29% | -0.91% | -41.79% | -89.62% | -45.33% | |
| Total Shareholder Return | -50.29% | -50.29% | -0.91% | -41.79% | -89.62% | -45.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.